Newscast – Page 176 – media

FDA approves Renovis Surgical’s 3D-printed posterior lumbar interbody fusion systems

The clearance for 3D-printed Tesera porous titanium interbody fusion systems has been secured from the US Food and Drug Administration (FDA) by Renovis Surgical Technologies.
- Source: orthopedicdevices
- 593
- August 15, 2017
Company Insight FDA interbody lumbar New Approvals
Neuros Medical, Evolent Health, Osprey Medical

Deals are reached by Neuros Medical, Evolent Health and Osprey Medical last week.
- Source: medicaldevice-network
- 729
- August 14, 2017
Clinical R&D Researches
Esophageal surgeries with robotic platforms safe and effective

Transchiatal esophagectomy procedures utilizing robotic platforms are “effective and safe” for carefully selected patients, according to a new study from Allina Health hospitals.
- Source: massdevice
- 590
- August 14, 2017
esophagectomy lymph Researches
£2m UK consortium to tackle gene therapy

A two-year, £2 million project focused on gene and cell therapy manufacturing will be embarked on by Oxford BioMedica, will embark on.
- Source: news.open-medical
- 730
- August 14, 2017
cell Company Insight gene therapy
FDA clears AUM’s diagnostic cardiovascular device

The US Food and Drug Administration (FDA) has cleared AUM Cardiovascular’s acoustic and electrocardiogram (ECG) device called CADence to aid detection of physiological and pathological heart murmurs.
- Source: medicaldevice-network
- 683
- August 11, 2017
CADence cardiovascular FDA heart New Approvals
New research uncovers how dietary fiber helps intestinal cells maintain gut health

UC Davis Health researchers have discovered how by-products of the digestion of dietary fiber by gut microbes act as the right fuel to help intestinal cells maintain gut health.
- Source: news-medical.net
- 713
- August 11, 2017
gut Researches
Positive outlook for biotech M&A and funding, says report

A report examining the European venture landscape for health and biotech firms over the first half of 2017 has found that there is a continuing positive environment for venture funding and M&A in the sector.
- Source: news.open-medical
- 586
- August 11, 2017
health M&A Market Views
Roche out-licneses lebrikizumab to Dermira

Roche has agreed to out-license certain rights to its invesitgational atropic dermatitis drug lebrikizumab to Demira in a deal that could be worth more than $1.4 billion.
- Source: pharmatimes
- 632
- August 10, 2017
Company Insight dermatitis Dermira lebrikizumab Market Views
Kite begins EU trial of CAR–T therapy

Kite Pharma has begun treating the first EU patients with its investigational CAR–T candidate, axicabtagene ciloleucel (axi-cel), in the safety expansion cohort of the ZUMA-1 trial.
- Source: pharmatimes
- 1,238
- August 10, 2017
CAR–T Clinical Trials Company Insight EU FDA
New study examines potential Alzheimer’s disease prevention strategies

The future of researching ways to prevent AD should probably focus on people at risk for developing the disease, said researchers, and should highlight how to improve management of chronic health conditions and education about living healthier.
- Source: news-medical
- 733
- August 10, 2017
Alzheimer's chronic Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.